Back to search

Switzerland· 67596004

Enerzair Breezhaler Inha

A indacaterol, glycopyrronium bromid und mometason product containing indacaterolum, glycopyrronium, mometasoni furoas, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC R03AL12

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedEnerzair Breezhaler InhaATCR03AL12REGISTER NO.67596004PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Indacaterol, glycopyrronium bromid und mometason is registered in 11 of 19 countries.

Countries holding a registration under ATC R03AL12 (indacaterol, glycopyrronium bromid und mometason), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Indacaterol, glycopyrronium bromid und mometason · ATC R03AL12

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
indacaterolum, glycopyrronium, mometasoni furoas
Manufacturer
—
Country
Switzerland (CH)
ATC code
R03AL12
ATC class
Indacaterol, Glycopyrronium bromid und Mometason
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680675960040
    Blist 30 Stk
    CHF 75.8

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c55f3124-23c3-43c1-b9e0-66fd55771ac3
GET /v1/drugs/c55f3124-23c3-43c1-b9e0-66fd55771ac3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "indacaterolum 150 mcg + glycopyrronium 50 mcg + mometasoni-17 furoas 160 mcg",
  "valid_from": "2021-01-01",
  "limitations": "[{\"description\":\"Zur Erhaltungstherapie von Patienten mit schwerem Asthma, welche mit einer Erhaltungstherapie aus einem lang wirksamen Beta2-Agonisten und einem hochdosierten inhalativen Kortikosteroid nicht ausreichend eingestellt sind und eine oder mehr Exazerbationen in den letzten 12 Monaten erlitten haben<br>\\noder<br>\\nfür Patienten mit schwerem Asthma, welche bereits mit einer Kombination von LABA/LAMA und ICS mit mehreren Inhalatoren therapiert werden.<br>\\n<br>\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2021-01-01\",\"validTo\":null}]",
  "galenic_form": "Inh Kaps 150/50/160mcg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2021-01-01",
  "self_retention_pct": 10
}

See everything about indacaterol, glycopyrronium bromid und mometason.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.